S.Biomedics Balance Sheet Health
Financial Health criteria checks 4/6
S.Biomedics has a total shareholder equity of ₩11.1B and total debt of ₩11.5B, which brings its debt-to-equity ratio to 103.3%. Its total assets and total liabilities are ₩30.4B and ₩19.3B respectively.
Key information
103.3%
Debt to equity ratio
₩11.49b
Debt
Interest coverage ratio | n/a |
Cash | ₩9.56b |
Equity | ₩11.12b |
Total liabilities | ₩19.28b |
Total assets | ₩30.41b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A304360's short term assets (₩14.3B) exceed its short term liabilities (₩7.5B).
Long Term Liabilities: A304360's short term assets (₩14.3B) exceed its long term liabilities (₩11.8B).
Debt to Equity History and Analysis
Debt Level: A304360's net debt to equity ratio (17.3%) is considered satisfactory.
Reducing Debt: A304360's debt to equity ratio has increased from 31.3% to 103.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A304360 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A304360 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 10.9% each year